¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"muscarinic synapse"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® synapse ÇÑ±Û ½Ã³À½º
¼³¸í   
  ¿µ±¹ÀÇ ¼Î¸µÅÏ(Sherrington)ÀÌ 1897³â ÃÖÃʷΠ¸í¸íÇÑ ¿ë¾î·Î½á ½Å°æ¼¼Æ÷ÀΠ´º·Ð°ú ´º·ÐÀÌ ¸¸³ª´Â °÷À» ÀǹÌÇÔ. ½Ã³À½º¿¡´Â È­Çй°ÁúÀÇ À¯¸®¿¡ ÀÇÇØ ÈïºÐÀ» Àü´ÞÇϴ ȭÇнóÀ½º(chemical synapse)¿Í Àü±âÀûÀ¸·Î ÈïºÐÀÌ Á÷Á¢ Àü´ÞµÇ´Â Àü±â ½Ã³À½º(electrical synapse)·Î ºÐ·ùµÈ´Ù.
  
  Àü±â ½Ã³À½º´Â ½Ã³À½ºÀü´º·Ð(presynaptic neuron)°ú ½Ã³À½ºÈÄ´º·Ð(postsynaptic neuron)ÀÇ °£°ÝÀÌ °ÅÀÇ ¾øÀ¸¸ç Àü·ù°¡ ½±°Ô È带 ¼ö Àִ ³·Àº ÀúÇ×ÀÇ gap junctionÀ» Çü¼ºÇÏ¿© ½Ã³À½º¿¡¼­ÀÇ ÈïºÐÀüµµ°¡ ÀϹÝÀûÀΠ´ÜÀϽŰ漶À¯³ª µ¿Àϼ¼Æ÷³»¿¡¼­ÀÇ Àü±âÀû Àüµµ¿Í ±Ùº»ÀûÀ¸·Î µ¿ÀÏÇÏ´Ù.
  
  È­ÇР½Ã³À½º´Â ½Ã³À½ºÀü´º·Ð°ú ½Ã³À½ºÈÄ´º·Ð»çÀÌ¿¡ ¾à 20nmÀÇ Æ´, ÁóÀ½º°£°Ý(synaptic cleft)ÀÌ Á¸ÀçÇϸç Àü´º·Ð¸»´Ü¿¡´Â Àü´Þ¹°ÁúÀ» ³»Æ÷Çϴ vesicleÀÌ ¸¹ÀÌ Á¸ÀçÇϸç, ½Ã³À½ºÀüµµ½Ã Àü´º·ÐÀÇ vesicle·ÎºÎÅÍ ½Å°æÀü´Þ¹°ÁúÀÌ À¯¸®µÇ¾î È®»ê¿¡ ÀÇÇØ ÈÄ´º·ÐÀÇ ¼ö¿ëü¿¡ µµ´ÞÇÏ¿© °áÇÕÇÑ´Ù. ÀÌ·¯ÇÑ ½Å°æÀü´Þ¹°ÁúÀÇ À¯¸®¿¡´Â Ca ÀÌ¿ÂÀÇ À¯ÀÔÀÌ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • muscarinic
    ¹«½ºÄ«¸°-
  • muscarinic agonist
    ¹«½ºÄ«¸°ÀÛ¿ëÁ¦
  • muscarinic antagonist
    ¹«½ºÄ«¸°´ëÇ×Á¦
  • muscarinic receptor
    ¹«½ºÄ«¸°¼ö¿ëü
  • axoaxonic synapse
    Ãà»èÃà»è½Ã³À½º, Ãà»èÃà»è¿¬Á¢
  • axodendritic synapse
    Ãà»è¼ö»óµ¹±â½Ã³À½º, Ãà»è°¡Áöµ¹±â¿¬Á¢
  • axosomatic synapse
    Ãà»è¼¼Æ÷ü½Ã³À½º, Ãà»è¼¼Æ÷ü¿¬Á¢
  • central synapse
    ÁßÃ߽óÀ½º, ÁßÃß¿¬Á¢
  • chemical synapse
    È­ÇнóÀ½º, È­Çп¬Á¢
  • excitatory synapse
    ÈïºÐ½Ã³À½º, ÈïºÐ¿¬Á¢
  • electrical synapse
    Àü±â½Ã³À½º, Àü±â¿¬Á¢
  • inhibitory synapse
    ¾ïÁ¦½Ã³À½º, ¾ïÁ¦¿¬Á¢
  • neuromuscular synapse
    ½Å°æ±Ù(À°)½Ã³À½º, ½Å°æ±Ù(À°)¿¬Á¢
  • synapse
    ½Ã³À½º, ¿¬Á¢
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • synapse
    ¿¬Á¢, ½Ã³À½º, ½Å°æ¼¼Æ÷Á¢ÇÕºÎ
  • neuromuscular synapse
    ½Å°æ±ÙÀ°¿¬Á¢
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • muscarinic agonist
    ¹«½ºÄ«¸°ÀÛ¿ëÁ¦
  • muscarinic antagonist
    ¹«½ºÄ«¸°´ëÇ×Á¦
  • muscarinic receptor
    ¹«½ºÄ«¸°¼ö¿ëü
  • axoaxonic synapse
    Ãà»èÃà»è¿¬¿±
  • axodendritic synapse
    Ãà»è°¡Áöµ¹±â¿¬Á¢
  • axosomatic synapse
    Ãà»è¼¼Æ÷ü¿¬Á¢
  • central synapse
    ÁßÃß¿¬Á¢
  • chemical synapse
    È­Çп¬Á¢
  • collateral synapse
    °ç¿¬Á¢
  • dendrodendritic reciprocal synapse
    °¡Áöµ¹±â»óÈ£¿¬Á¢
  • electrical synapse
    Àü±â¿¬Á¢
  • excitatory synapse
    ÈïºÐ¿¬Á¢
  • inhibitory synapse
    ¾ïÁ¦¿¬Á¢
  • invaginate synapse
    ¿À¸ñ¿¬Á¢
  • neuromuscular synapse
    ½Å°æ±ÙÀ°¿¬Á¢
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • M1 muscarinic receptors
    M1 ¹«½ºÄ«¸°¼º ¼ö¿ëü(áôé»ô÷)
  • artificial synapse
    Àΰø½Ã³³½º.
  • inhibitory synapse
    ¾ïÁ¦¼º(åäð¤àõ) ½Ã³³½º.
  • inhibitory synapse
    ¾ïÁ¦¼º ½Ã³³½º.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nonvesicular synapse [electrical synapse]
    ¹«¼ÒÆ÷¿¬Á¢ (Àü±â¿¬Á¢)
  • muscarinic
    ¹«½ºÄ«¸°(ÀÛµ¿)¼º.
  • muscarinic agonist
    ¹«½ºÄ«¸°¼ºÀÛ¿ëÁ¦
  • muscarinic antagonist
    ¹«½ºÄ«¸°¼º±æÇ×Á¦
  • muscarinic effect
    ¹«½ºÄ«¸°¼ºÈ¿°ú(¡­àõüùÍý).
  • muscarinic effect
    ¹«½ºÄ«¸°¾çÈ¿°ú (¡­åÆüùÍý).
  • muscarinic receptor
    ¹«½ºÄ«¸° ¼ö¿ëü
  • artificial synapse
    Àΰø½Ã³³½º.
  • axo axonic synapse
    Ãà»èÃà»è°£(¡­õîßãÊà) ½Ã³³½º
  • axo dendritic synapse
    Ãà»è¼ö»óµ¹±â°£(~â§ßÒÔÍÑÃÊà)½Ã³³½º
  • axoaxonal synapse
    Ãà»è»çÀÌ¿¬Á¢
  • axodendritic synapse
    Ãà»è°¡Áöµ¹±â¿¬Á¢
  • axodendrosomatic synapse
    Ãà»è¼ö»ó¼¼Æ÷ü°£½Ã³³½º
  • axosomatic synapse
    Ãà»è¼¼Æ÷ü°£¿¬Á¢
  • axosomatic synapse
    Ãà»è¼¼Æ÷ü¿¬Á¢
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Nonvesicular synapse [Electrical synapse]
    ¹«¼ÒÆ÷¿¬Á¢ [Àü±â¿¬Á¢]
    [¿¾ ¿ë¾î] ¹«¼ÒÆ÷½Å°æ¿¬Á¢
  • Dendrodendritic synapse
    °¡Áöµ¹±â»çÀÌ¿¬Á¢
    [¿¾ ¿ë¾î] ¼ö»óµ¹±â°£¿¬Á¢
  • Somatodendritic synapse
    ¼¼Æ÷ü°¡Áöµ¹±â¿¬Á¢
    [¿¾ ¿ë¾î] ¼¼Æ÷ü¼ö»óµ¹±â¿¬Á¢
  • Somatosomatic synapse
    ¼¼Æ÷ü»çÀÌ¿¬Á¢
    [¿¾ ¿ë¾î] ¼¼Æ÷ü°£¿¬Á¢
  • Vesicular synapse
    ¼ÒÆ÷¿¬Á¢
    [¿¾ ¿ë¾î] ¼ÒÆ÷½Å°æ¿¬Á¢
  • Synapse
    ¿¬Á¢
    [¿¾ ¿ë¾î] ¿¬Á¢
  • Invaginate synapse
    ¿À¸ñ¿¬Á¢
    [¿¾ ¿ë¾î] ÇÔÀÔ¿¬Á¢
  • Axodendritic synapse
    Ãà»è°¡Áöµ¹±â¿¬Á¢
    [¿¾ ¿ë¾î] Ãà»è¼ö»óµ¹±â¿¬Á¢
  • Axoaxonal synapse
    Ãà»è»çÀÌ¿¬Á¢
    [¿¾ ¿ë¾î] Ãà»è°£¿¬Á¢
  • Axosomatic synapse
    Ãà»è¼¼Æ÷ü¿¬Á¢
    [¿¾ ¿ë¾î] Ãà»è¼¼Æ÷ü¿¬Á¢
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • muscarinic synapse
    ¹«½ºÄ«¸°½Ã³³½º
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • muscarinic receptor
    ¹«½ºÄ«¸°¼ö¿ëü(áôéÄô÷)
  • chemical synapse
    È­ÇÐ(ûùùÊ) ½Ã³³½º
  • nicotinic synapse
    "´ÏÄÚÆ¾½Ã³³½º, ´ÏÄÚÆ¾¿¬Á¢ºÎ(Ö§ïÈÝ»)"
  • synapse
    ½Ã³³½º
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • synapse
    ½Ã³³½º, Á¢ÇÕºÎ, ¿¬Á¢
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
mAChR muscarinic acetylcholine receptor
SYN synapse; synovitis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
M2 Muscarinic
mAChRs Muscarinic ACh receptors
mAChR Muscarinic acetylcholine receptor
mAChR Muscarinic cholinergic receptors
mAChR Muscarinic receptor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • axoaxonal synapse
    Ãà»è »çÀÌ ¿¬Á¢
  • excitatory synapse
    ÈïºÐ¼º ½Ã³³½º
  • inhibitory synapse
    ¾ïÁ¦¼º ½Ã³³½º
  • synapse
    ½Ã³³½º, Á¢ÇÕºÎ, ¿¬Á¢, ½Ã³À½º, ½Å°æ ¿¬Á¢
    µ¿ÀǾî=syna
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
receptors, muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for muscarine over nicotine. There are several subtypes (usually m1, m2, m3...) that are characterised by their cellular actions, pharmacology, and molecular biology.
(12 Dec 1998)
muscarinic 1. Having a muscarine-like action, i.e., producing effects that resemble postganglionic parasympathetic stimulation.
2. An agent that stimulates the postganglionic parasympathetic receptor.
See: muscarine, nicotinic.
(05 Mar 2000)
muscarinic acetylcholine receptor Distinct from the nicotinic ACh receptor in having no intrinsic ion channel, the receptor is formed from one protein chain with 7 transmembrane regions. The receptors produce their effect via activation of GTP-binding proteins.
(18 Nov 1997)
muscarinic agonist Drugs that bind to and activate muscarinic cholinergic receptors (receptors, muscarinic). Muscarinic agonists are most commonly used when it is desirable to increase smooth muscle tone, especially in the GI tract, urinary bladder and the eye. They may also be used to reduce heart rate.
(12 Dec 1998)
muscarinic antagonist Drugs which bind with muscarinic cholinergic receptors but do not activate them, thus preventing access to acetylcholine; examples include atropine, scopolamine, propantheline, and pirenzepine.
(05 Mar 2000)
muscarinic antagonists Drugs that bind to but do not activate muscarinic cholinergic receptors (receptors, muscarinic), thereby blocking the actions of endogenous acetycholine or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. Antagonists that discriminate among the various muscarinic receptor subtypes and might allow better control of peripheral and central actions are under development.
(12 Dec 1998)
muscarinic receptor kinase <enzyme> Phosphorylates muscarinic acetylcholine receptors and beta-adrenergic receptors
Registry number: EC 2.7.-
Synonym: muscarinic acetylcholine receptor kinase, machr kinase
(26 Jun 1999)
muscarinic receptors Membrane-bound proteins whose extracellular domain contains a recognition site for acetylcholine (ACh); combination of Ach with the receptor initiates a physiologic change (slowing of heart rate, increased glandular secretory activity and stimulation of smooth muscle contractions); changes are observed after treatment with the mushroom alkaloid, muscarine. Muscarinic receptors are to be distinguished from nicotinic receptors.
(05 Mar 2000)
axoaxonic synapse The synaptic junction between an axon terminal of one neuron and either the initial axon segment or an axon terminal of another nerve cell.
(05 Mar 2000)
axodendritic synapse The synaptic contact between an axon terminal of one nerve cell and a dendrite of another nerve cell.
(05 Mar 2000)
axosomatic synapse The synaptic junction of an axon terminal of one nerve cell to the cell body of another nerve cell.
Synonym: pericorpuscular synapse.
(05 Mar 2000)
rectifying synapse <physiology> An electrical synapse at which current flow can only occur in one direction.
(18 Nov 1997)
pericorpuscular synapse The synaptic junction of an axon terminal of one nerve cell to the cell body of another nerve cell.
Synonym: pericorpuscular synapse.
(05 Mar 2000)
chemical synapse <physiology> A nerve nerve or nerve muscle junction where the signal is transmitted by release from one membrane of a chemical transmitter that binds to a receptor in the second membrane. Importantly, signals only pass in one direction.
(18 Nov 1997)
ribbon synapse <biology, physiology> Ultrastructurally distinct type of synapse found in a variety of sensory receptor cells such as retinal photoreceptor cells, cochlear hair cells and vestibular organ receptors, as well as in a nonsensory neuron, the retinal bipolar cell.
Unlike most neurons, these cells do not use regenerative action potentials but release transmitter in response to small graded potential changes. Ribbon synapses have different exocytotic machinery from conventional synapses in containing dense bars or ribbons anchored to the presynaptic membrane covered with a layer of synaptic vesices. The ribbons have been proposed to shuttle synaptic vesicles to exocytotic sites.
(23 Aug 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • synapse
    ½Ã³À½º;½Å°æ ¼¼Æ÷ ¿¬Á¢(ºÎ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á